Skip to main content
Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.740
+0.110 (6.75%)
At close: Mar 9, 2026, 4:00 PM EDT
1.720
-0.020 (-1.15%)
After-hours: Mar 9, 2026, 5:51 PM EDT

Palisade Bio Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
8
Market Cap
259.27M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 2023250.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cellectis 82.55M
Fennec Pharmaceuticals 38.79M
Prelude Therapeutics 10.50M
Ovid Therapeutics 6.61M
Surrozen 3.60M
Camp4 Therapeutics 3.50M
Orchestra BioMed Holdings 2.82M
Inhibikase Therapeutics 1.00
Revenue Rankings

PALI News

More News